将代谢干预转化为乳腺癌治疗:综合性审查
Luxi Chen1, Stephen L Shiao2, Yuan Yuan1
1Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Life (Basel, Switzerland)
|October 29, 2025
概括
代谢失调与乳腺癌的进展和复发有关. 抗糖尿病和抗肥胖药物通过向代谢途径和瘤生长,显示出作为新型乳腺癌疗法的前景.
科学领域:
- 在瘤学瘤学.
- 代谢综合征是代谢综合征的一种.
- 药理学 药理学 是一个学科.
背景情况:
- 乳腺癌是全球主要的健康问题,目前治疗方法的长期疗效有限.
- 治疗耐药性,代谢毒性和复发仍然是重大挑战.
- 代谢综合征和失调是乳腺癌发展,进展和死亡率的关键风险因素.
研究的目的:
- 审查代谢失调和乳腺癌的交叉点.
- 评估乳腺癌治疗中代谢疗法的临床前和临床证据.
主要方法:
- 对当前知识的文献综述.
- 临床前和临床研究的批判性评价.
- 分析将新陈代谢与癌症联系起来的信号通路 (如胰岛素/IGF,PI3K/AKT/mTOR).
主要成果:
- 代谢失调与乳腺癌的进展,复发和死亡率密切相关.
- 抗糖尿病和抗肥胖药物表现出超出代谢益处的潜力.
- 这些药物可以直接影响瘤细胞生长,免疫反应和关键的瘤性途径.
结论:
- 代谢综合征和失调是乳腺癌的关键因素.
- 代谢疗法,包括抗糖尿病和抗肥胖药物,代表了一个有前途的新疗法策略.
- 需要进一步的研究和临床评估,以将代谢疗法纳入乳腺癌治疗范式.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


